Groupe Bruxelles Lambert SA GBLBY · OTC
$8.67 -5.71% (-$0.53)
Summary
45 / 100 · Bulios Score
What speaks for it
- It bought back its own shares for 321.7M € in the last fiscal year, 3.2% of its market value.
- The price moves less than the market (beta 0.66).
What to watch
- The company made a loss over the last 12 months.
- The share price is above the Bulios Fair Price.
- Revenue grew by only 0.5% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue fell by 0.4% a year over 5 years. Over the last 3 years it grew by 0.5% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of 496.1M €.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 6.48%
- Raised in a row
- 1 year
You receive $0.60 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.